Aurinia Pharmaceuticals Inc. (AUPH) Total liabilities 2019–2025
Aurinia Pharmaceuticals Inc. (AUPH) total liabilities at each fiscal year-end, per SEC filings.
$170.3MFY2025 · since FY2019: $25.7M → $170.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $170.3M | -1.7% |
| FY2024 | $173.2M | +1.8% |
| FY2023 | $170.1M | +160.0% |
| FY2022 | $65.4M | +1.8% |
| FY2021 | $64.3M | +15.0% |
| FY2020 | $55.9M | +117.5% |
| FY2019 | $25.7M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More AUPH financial trends
AUPH RevenueAUPH Net incomeAUPH Net marginAUPH Gross profitAUPH Gross marginAUPH Operating incomeAUPH Operating marginAUPH Operating cash flowAUPH Free cash flowAUPH Capital expendituresAUPH Return on equityAUPH Stock buybacksAUPH Dividends paidAUPH Total assetsAUPH Shareholders’ equityAUPH overview →